Investigating Real-World Benztropine Usage Patterns in Movement Disorders: Claims Analysis and Health Care Provider Survey Results

Conclusions: These complementary analyses suggest that benztropine is used long-term in non-tardive dyskinesia drug-induced movement disorders and in tardive dyskinesia despite risks of worsening tardive dyskinesia or adverse effects.Prim Care Companion CNS Disord 2023;25(4):22m03472.Author affiliations are listed at the end of this article.PMID:37671827 | DOI:10.4088/PCC.22m03472

Source: The Primary Care Companion for CNS Disorders - September 6, 2023 Category: Primary Care Authors: Craig Chepke Betsy Benning Samantha Cicero Michael Hull Erika Giraldo Jason Yeaw Katharine Coyle Eric Jen Morgan Bron Source Type: research